News & Media

SLIP-COAT is the ideal product for manufacturers looking to achieve a specified level of lubricity to aid with all manner of insertion, from arterial to venous and more.

Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S. The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via a jugular approach.

Argon Medical Devices, Inc,. a leading global manufacturer of specialty medical devices used in interventional procedures, announced today that it has entered into a definitive license agreement with Hatch Medical, L.L.C. (“Hatch Medical”) for exclusive global rights to market and distribute the Scorpion™ TIPS Access Systems.

Argon Medical Devices, Inc., a global manufacturer of specialty medical devices used in interventional procedures, announced today that it has completed the acquisition of Mana-Tech, Ltd., its exclusive distributor for the United Kingdom & Ireland

Dr. Thor Johnson discusses his experience with Argon Medical's BioPince biopsy needle for liver, renal and soft tissue biopsies, including tips and tricks for obtaining better biopsy samples with fewer passes. Recorded at SIR 2019 in ATX.

Dr. David Mobley of Columbia University VIR describes his over-the-wire technique to prevent tilting in IVC filter placement.

From the Exhibitor's Hall at SIR 2018 in Los Angeles, Dr. Chris Beck and Dr. Sabeen Dhand describe their declot techniques, with an emphasis on when and how they use Argon Medical's Cleaner device for these cases.

PLANO, TX — Argon Medical Devices, Inc. (Argon), a leading global manufacturer and marketer of specialty medical devices used in interventional procedures, announced today that it has formalized a Medical Advisory Board comprised of distinguished physicians from institutions across the United States who specialize in interventional medicine. The Medical Advisory Board will continue to provide scientific and clinical expertise to guide the organization in planning and implementing product development initiatives and marketing programs with the goal of improving the lives of patients and their caregivers.

Divestiture positions Argon to increase focus on the growth and expansion of its Interventional business

Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc. Prior to this transaction, the products were licensed and distributed by Argon through an exclusive agreement with Rex Medical. All three best-in-class product families have displayed significant growth under Argon’s leadership. The addition of these safe and proven technologies to Argon Medical’s portfolio firmly establishes the company’s position as a market leader in the treatment of venous disease.

Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the CLEANER XT™ and CLEANER 15™ Rotational Thrombectomy Systems for mechanical declotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature.

PLANO, Texas, May 6, 2014/PRNewswire/ —Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT™ Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products. With increased power and torque for cleaning wall-adherent thrombus, and the ability to be introduced through a 6 Fr sheath, CLEANERXT combines torque with trackability. Its innovative sinusoidal wire design is radiopaque and conforms to varying lumen diameters, actively cleaning wall-adherent thrombus.

PLANO, Texas, Jan. 16, 2014/PRNewswire/ – Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the Option™ELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire delivery technique. This new clearance enables physicians to safely deliver the filter to a patient’s IVC by following the path of a guidewire. The guidewire assists in keeping the filter centered in the IVC upon placement. The over-the-wire technique is a standard of care in many endovascular procedures and the OptionELITE is the only retrievable IVC filter that can be delivered by passing the filter’s apex over a guidewire.

LAKE FOREST, IL, MARCH 25, 2013 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon” or the “Company”), entered into a definitive agreement to acquire the Interventional Products Business of Angiotech Pharmaceuticals, Inc. (“Angiotech”). The Interventional Products Business manufactures and markets disposable and re-usable biopsy products for the diagnosis of cancer, drainage catheter products, and vascular interventional products. The transaction is expected to be completed prior to the end of April 2013 subject to customary closing conditions.

Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15™ Rotational Thrombectomy System. The addition of Cleaner15™ to Argon Medical’s product portfolio provides physicians with another weapon in their arsenal to safely and effectively restore patency in occluded arteriovenous fistulae and synthetic grafts.

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, is pleased to announce that Argon Medical (LiDCO’s partner in Japan) has confirmed that the LiDCOrapid Monitor and associated disposable products have been successfully approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). LiDCO believes that Japan is the second largest market in the world for hemodynamic monitoring with approximately 680,000 high-risk surgical patients per annum who would benefit clinically from improved intraoperative fluid management.

PLANO, Texas, March 22, 2012 – Argon Medical Devices, Inc. announced today the US launch of the UltraStream Chronic Hemodialysis catheter, licensed from Rex Medical, LP, designed to provide long-term vascular access to patients receiving dialysis treatments.

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with Argon Medical Devices, Japan, K.K. (“Argon Medical”) to register with the Japanese Ministry of Health, Labour and Welfare the LiDCOrapid monitor and disposable kit for the Japanese market.

ATHENS, TX, March 15th, 2011 – Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP (“Rex Medical”) for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).

Argon Medical Devices, Inc. announced that it has entered into a definitive licensing agreement with Rex Medical, LP (“Rex Medical”) for exclusive rights to market and distribute the UltraStream chronic dialysis catheter ™ on a global basis. UltraStream™ is designed to provide long-term vascular access to patients receiving dialysis treatments.

Acquisition Positions Argon as a Leading Provider of Products in Interventional Radiology, Critical Care and Cardiac Catheterization Markets